Latest News in the pharma Industry

Policy & Regulation

Merck's Idenix Pharmaceuticals awarded $2.54 billion for infringement of a hepatitis C drug patent

Merck's Idenix Pharmaceuticals awarded $2.54 billion for infringement of a hepatitis C drug patent

16 Dec 2016

In its decision, the jury also concluded that Gilead “willfully” infringed upon the patent.

Read more 
FDA approves Synjardy XR tablets for adults with type 2 diabetes

FDA approves Synjardy XR tablets for adults with type 2 diabetes

13 Dec 2016

New once-a-day formulation indicated to improve blood sugar when used along with diet and exercise.

Read more 
Novartis' Lucentis received EU approval in new indication

Novartis' Lucentis received EU approval in new indication

10 Dec 2016

Lucentis the only treatment available for a wide range of CNV conditions.

Read more 
Mederi's Stretta Therapy for GERD approved in China

Mederi's Stretta Therapy for GERD approved in China

9 Dec 2016

Clinically proven and cost-effective solution for gastroesophageal reflux disease recently launched in China.

Read more 
Pfizer refutes the findings set out in the CMA decision

Pfizer refutes the findings set out in the CMA decision

8 Dec 2016

Pharma giant says it complied with established competition law.

Read more 
FDA approves Jardiance tablets to reduce the risk of cardiovascular death in adults with T2D

FDA approves Jardiance tablets to reduce the risk of cardiovascular death in adults with T2D

5 Dec 2016

The only oral T2D medicine to provide a life-saving cardiovascular benefit.

Read more 
GSK's Relvar Ellipta gains approval in Japan for COPD patients

GSK's Relvar Ellipta gains approval in Japan for COPD patients

3 Dec 2016

Read more 
FDA accepts BLA for avelumab for the treatment of metastatic MCC for Priority Review

FDA accepts BLA for avelumab for the treatment of metastatic MCC for Priority Review

29 Nov 2016

If approved by the FDA, avelumab could be the first treatment indicated for patients with metastatic Merkel cell carcinoma.

Read more 
European Commission approves BMS's Opdivo for Hodgkin's

European Commission approves BMS's Opdivo for Hodgkin's

24 Nov 2016

Opdivo is now the first and only PD-1 inhibitor approved for a hematologic malignancy in the European Union.

Read more 
NICE ‘yes’ to Imnovid in the fight against the biggest blood cancer killer in the UK

NICE ‘yes’ to Imnovid in the fight against the biggest blood cancer killer in the UK

23 Nov 2016

Pomalidomide available to people in England immediately via the Cancer Drugs Fund.

Read more 
FDA gives green light to Sanofi's once-daily Soliqua 100/33

FDA gives green light to Sanofi's once-daily Soliqua 100/33

22 Nov 2016

The type 2 diabetes treatment for adults will be delivered using SoloStar technology.

Read more 
Allergan receives FDA clearance for the XEN Gel Stent

Allergan receives FDA clearance for the XEN Gel Stent

22 Nov 2016

The XEN Glaucoma Treatment System reduces intraocular pressure in patients with refractory glaucoma.

Read more